Short Interest in Sintx Technologies, Inc. (NASDAQ:SINT) Expands By 20.6%

Sintx Technologies, Inc. (NASDAQ:SINT) saw a significant growth in short interest during the month of March. As of March 31st, there was short interest totaling 255,636 shares, a growth of 20.6% from the March 15th total of 211,999 shares. Based on an average daily trading volume, of 34,109 shares, the short-interest ratio is presently 7.5 days. Approximately 6.5% of the shares of the company are sold short.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Geode Capital Management LLC boosted its position in Sintx Technologies by 33.5% in the second quarter. Geode Capital Management LLC now owns 15,339 shares of the company’s stock worth $49,000 after purchasing an additional 3,848 shares during the last quarter. Virtus Wealth Solutions LLC purchased a new position in Sintx Technologies in the third quarter worth about $388,000. Finally, Veracity Capital LLC boosted its position in Sintx Technologies by 10.3% in the third quarter. Veracity Capital LLC now owns 79,928 shares of the company’s stock worth $327,000 after purchasing an additional 7,464 shares during the last quarter. 18.38% of the stock is owned by hedge funds and other institutional investors.

Sintx Technologies Price Performance

Sintx Technologies stock opened at $2.69 on Friday. Sintx Technologies has a one year low of $1.72 and a one year high of $6.78. The stock has a market capitalization of $11.08 million, a PE ratio of -0.48 and a beta of 0.66. The business’s fifty day moving average is $2.75 and its 200 day moving average is $3.33.

Wall Street Analyst Weigh In

SINT has been the topic of several recent analyst reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Sintx Technologies in a research report on Thursday, January 22nd. HC Wainwright initiated coverage on Sintx Technologies in a research report on Monday, April 13th. They set a “buy” rating and a $10.00 price objective on the stock. Finally, Ascendiant Capital Markets dropped their price objective on Sintx Technologies from $16.00 to $12.00 and set a “buy” rating on the stock in a research report on Wednesday, April 8th. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, Sintx Technologies has a consensus rating of “Hold” and a consensus target price of $11.00.

About Sintx Technologies

Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.

The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.